Dr. Michael Alan Jantz, MD

Dr. Jantz practices at HCA Florida North Florida Hospital in Gainesville, Florida, part of HCA Healthcare.

Dr. Jantz's NPI, 1225077159, was assigned on June 6, 2006. Dr. Jantz graduated from University Of Washington School Of Medicine in 1989. Dr. Jantz holds Florida license ME80449.

Dr. Jantz's primary practice is HCA Florida North Florida Hospital, at 6500 W Newberry Rd, Gainesville, FL 32605 in Alachua County. The practice phone is (352) 333-4100.

Dr. Jantz's primary practice is HCA Florida North Florida Hospital in Gainesville, Florida, part of HCA Healthcare. Dr. Jantz is also affiliated with UF Health Shands Hospital. The medical group on file is North Florida Surgical Associates. Dmand AI also links Dr. Jantz to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jantz practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Jantz's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Jantz is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Jantz's licenses on file in 3 states: Florida, South Carolina and Washington.

CMS data shows 1,508 Medicare services from Dr. Jantz across 17 procedure codes in 2024, for 457 Medicare patients. Medicare paid $144,927 for them.

CMS counts 457 Medicare patients who saw Dr. Jantz in 2024. The largest group is 75 to 84, with 193 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jantz's median patient age at 73, with 51% women.

In 2024, Dr. Jantz wrote 1,026 Medicare Part D claims for 172 patients. 56% of them were for generic drugs. CMS names the drug for 827 of them, across 24 drugs with 11 or more claims each, at $423,106 in total drug cost. In 2023, CMS named 656 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Jantz for performance year 2024, reported individually. Dr. Jantz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jantz as offering telehealth.

Dmand AI links 67 papers to Dr. Jantz, published from 2009 to 2022. 2019 was the busiest year, with 6. The most frequent topics are Bronchoscopy, Lung Neoplasms and Carcinoma, Non-Small-Cell Lung. Dr. Jantz has published most often in Chest. Dr. Jantz's most frequent co-authors are Hiren Jitendra Mehta, MD, Sebastian Fernandez-Bussy, MD and Adnan Majid, MD.

Dmand AI links Dr. Jantz to 3 clinical trials. Conditions studied include Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung and Emphysema. University of Florida sponsors the most, 2.

CMS Open Payments shows 243 general payments to Dr. Jantz from 17 drug and device companies from 2016 to 2025. Education make up the largest share, 55% of the total. Intuitive Surgical, Inc. paid the most, $122,743.

Dmand AI lists 6 awards for Dr. Jantz, most recently America’s Best in Medicine in 2019.

Dr. Jantz graduated from University Of Washington School Of Medicine in 1989. Dr. Jantz is a member of ACCP and ATS.

Dr. Jantz is in network with 17 carriers, including Excellus BlueCross BlueShield, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.